Yuri Miyazawa

597 citations
33 papers · 464 indexed · h-index 10
Topics
Multiple Myeloma Research and Treatments (7 papers)Viral-associated cancers and disorders (5 papers)Peptidase Inhibition and Analysis (5 papers)
Partner nations
JapanUnited StatesCanada

In The Last Decade

Yuri Miyazawa

29 papers receiving 447 citations

Peers

Yuri Miyazawa
Comparison fields: 5 of 71
  • Molecular Biology 223
  • Oncology 160
  • Cancer Research 69
  • Urology 56
  • Hematology 55
Replace Ida Villanova with:
Ida Villanova Italy
Sebastian Kłosek Poland
Maura Pandolfi Italy
Takashi Kazama Japan
Valerie A. Siclari United States
Yang Xun China
Sarah Eichenberger United States
John P. Seery United Kingdom
É. Frouin France
K.M. Greulich United States
Yuri Miyazawa relative to Ida Villanova Italy Ida Villanova's profile →
Citations per field
00.5×4.9×
Ida Villanova · 1×
Citations per year

Countries citing papers authored by Yuri Miyazawa

Since Specialization
Citations

This map shows the geographic impact of Yuri Miyazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuri Miyazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuri Miyazawa more than expected).

Fields of papers citing papers by Yuri Miyazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuri Miyazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuri Miyazawa. The network helps show where Yuri Miyazawa may publish in the future.

Co-authorship network of co-authors of Yuri Miyazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yuri Miyazawa. A scholar is included among the top collaborators of Yuri Miyazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuri Miyazawa. Yuri Miyazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 12
6 2
7 5
8 1
9 11
10 4
11 55
12
Clinical experience of bendamustine for adult Langerhans cell sarcoma.
2
13 32
14 23
15 104
16 22
17 69
18 7
19 5
20
[Echocardiography in patients with malignant metastatic neoplasms of the heart and great vessels].
12

About Yuri Miyazawa

Yuri Miyazawa is a scholar working on Hematology, Oncology and Immunology and Allergy, having authored 33 papers that have together received 464 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Viral-associated cancers and disorders (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Urology (56 citations), Immunology and Allergy (50 citations) and Oncology (160 citations). Yuri Miyazawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Ryuichi Sakai, Takamasa Uekita, Yae Kanai, Satoko Fujii, Nobuyoshi Hiraoka, Tomoo Kosuge, Yoshihisa Nojima, Masamitsu Tanaka, Morio Matsumoto and Kazuyoshi Yanagihara. Their work appears in journals such as Blood, Cancer Research and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026